サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1791490

人工臓器とバイオニクスの世界市場

Artificial Organs and Bionics

出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
人工臓器とバイオニクスの世界市場
出版日: 2025年08月15日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

人工臓器とバイオニクスの世界市場は2030年までに710億米ドルに達する見込み

2024年に432億米ドルと推定される人工臓器とバイオニクスの世界市場は、2024年から2030年にかけてCAGR 8.6%で成長し、2030年には710億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである人工臓器は、CAGR 10.0%を記録し、分析期間終了時には451億米ドルに達すると予測されます。人工バイオニクス分野の成長率は、分析期間のCAGRで6.4％と推定されます。

米国市場は114億米ドル、中国はCAGR8.3%で成長すると予測

米国の人工臓器とバイオニクス市場は、2024年に114億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに113億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.1%と7.1%と予測されています。欧州では、ドイツがCAGR約6.7%で成長すると予測されています。

世界の「人工臓器とバイオニクス」市場- 主要動向と促進要因のまとめ

人工臓器とバイオニクスは人間の寿命と機能性をどのように再定義しているのか？

人工臓器とバイオニクスは、臓器が機能不全に陥ったり、身体機能が失われたりした患者に救命や生命増強の代替手段を提供することで、現代医療の展望に革命をもたらしています。人工心臓や人工腎臓から人工内耳やバイオニック四肢に至るまで、この分野は生物医学工学とロボット工学、電子工学、先端材料を融合させています。人工臓器は、移植への重要な橋渡しや、ドナー不足が続く場合の長期的な解決策の役割を果たします。一方、バイオニクスは運動、聴覚、視覚を回復させ、患者の自立と生活の質の回復を可能にします。これらの技術革新は、慢性疾患が蔓延する高齢化社会にとって特に重要です。神経インターフェイス、触覚フィードバック、リアルタイム・モニタリングの統合により、現代のバイオニクスはかつてないほど応答性が高く、本物そっくりになっています。下半身麻痺患者のリハビリや移動のための外骨格や、3Dプリントされた臓器足場は、以前は不可能と考えられていた限界を押し広げつつあります。小型化、バッテリー寿命、移植可能なバイオセンサーなどの絶え間ない改善により、よりスマートで患者に適応したデバイスが生み出されています。このように様々な分野が融合することで、ヘルスケアは、もはや障害が永久的な制限ではなく、臓器不全が死の宣告ではなくなる未来へと向かっています。

この分野のイノベーションを加速させている技術的ブレークスルーとは？

人工臓器とバイオニクスにおけるイノベーションは、再生医療、バイオマテリアル、AIを活用した診断、ロボット工学におけるブレークスルーによって推進されています。バイオプリンティング技術により、天然組織の特性を模倣できる脈管付き臓器構造の作成が可能になりつつあります。組織工学の進歩により、現在では実験室で成長させた皮膚、角膜、軟骨さえも人工インプラントと一体化させることができます。ブレイン・マシン・インターフェース（BMI）によって駆動される神経連動義肢は、思考による直感的なコントロールを可能にし、切断患者や脊髄損傷患者に新たな可能性を開きます。義肢に埋め込まれたセンサーは、握力や表面の質感などリアルタイムのフィードバックを提供し、ユーザー体験を大幅に向上させる。人工心臓や補助人工心臓では、磁気浮上式ローターとエネルギー効率の高いモーターによって安全性が向上し、装置の寿命が延びた。炭素繊維複合材とAIベースの動作パターン認識により、動力付き外衣を含むウェアラブル・バイオニクスは軽量化と低価格化が進んでいます。ナノコーティングと抗菌表面は、インプラントの生体適合性を向上させ、感染リスクを低減しています。機械学習アルゴリズムがより洗練されるにつれ、インスリンポンプ、ペースメーカー、腎補助装置のダイナミックな調整が可能になり、ヘルスケアの予測的洞察によるパーソナライズされたパフォーマンスが提供されます。

社会的、倫理的、経済的要因は市場の軌道に影響を与えるか？

人工臓器・バイオニクス市場が成熟するにつれ、その軌道は社会的受容、倫理的議論、償還政策によってますます形作られるようになっています。バイオニック手足や人工膵臓システムのサクセスストーリーが主流メディアに登場するにつれて、社会的認識は進化しているが、人間の強化、アイデンティティ、アクセスに関する倫理的疑問は依然として残っています。回復と増大の境界線は曖昧になりつつあり、何をもって「正常な」健康とするかについての議論につながっています。特に発展途上地域では、先進的な補綴物や移植可能な器具へのアクセスがまだ限られているため、コストが依然として重要な障壁となっています。多くの国の医療保険制度は、こうした高価な技術をより多くカバーするよう迫られているが、予算の制約は依然として残っています。また、複雑なバイオニックシステム、特に移植後のリハビリテーションを扱う訓練を受けた専門家も不足しています。世界の医療格差は、これらの技術がどこで、どのように採用されるかに影響を及ぼしています。一方、患者擁護団体は、救命機器に対する規制当局の迅速な承認を求めています。政府やNGOによる調査への資金提供や補助金支給の取り組みは勢いを増しているが、広く利用できるようにすることは依然として課題です。革新性、倫理性、手頃な価格のバランスをとることが、この変革の可能性を最大限に引き出す鍵となると思われます。

人工臓器とバイオニクス市場の成長は、いくつかの要因によって牽引されています。

慢性疾患や変性疾患の有病率の上昇、臓器提供者の世界の不足、医療技術革新への投資の増加などです。特に欧州と日本における世界の高齢化は、腎代替療法、心臓血管インプラント、補聴器に対する需要の急増に寄与しています。技術の進歩により、これらの機器はより正確でコンパクトになり、信頼性も高まっているため、ヘルスケアプロバイダーの間で採用が進んでいます。新興国では、ヘルスケア・インフラが整備され、保険適用範囲が拡大していることが、市場への浸透を促進しています。リハビリテーション分野では、医療と軍事の両分野でウェアラブル・バイオニック外骨格の需要が拡大しています。消費者の行動も変化しており、患者はますます情報を得るようになり、ライフスタイルと自律性を高める身体統合技術の採用に前向きになっています。高所得者市場では、運動能力や機能強化のためにバイオニック・ソリューションを選択的に使用するケースも出現しています。医療機関とハイテク企業との調査協力により、プロトタイピング、テスト、商品化の迅速化が進んでいます。新しいモデルでは、クラウドベースの健康データ統合が利用できるため、遠隔モニタリングや予測ケアが可能になり、これは特に遠隔医療プラットフォームにとって魅力的です。規制当局の支援と強力なイノベーション・パイプラインに支えられたこれらの動向は、市場の上昇軌道を確固たるものにしています。

セグメント

製品タイプ（人工臓器、人工バイオニクス）;技術（機械的バイオニクス技術、電子バイオニクス技術）

調査対象企業の例

  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Berlin Heart GmbH
  • Bornlife Prosthetic and Orthotic Inc.
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Edwards Lifesciences Corporation
  • Ekso Bionics Holdings Inc.
  • Getinge AB（Getinge Group）
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • Ossur
  • Sonova
  • SynCardia Systems, LLC
  • Zimmer Biomet Holdings, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29287

Global Artificial Organs and Bionics Market to Reach US$71.0 Billion by 2030

The global market for Artificial Organs and Bionics estimated at US$43.2 Billion in the year 2024, is expected to reach US$71.0 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. Artificial Organs, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$45.1 Billion by the end of the analysis period. Growth in the Artificial Bionics segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.4 Billion While China is Forecast to Grow at 8.3% CAGR

The Artificial Organs and Bionics market in the U.S. is estimated at US$11.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.1% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Global "Artificial Organs And Bionics" Market - Key Trends & Drivers Summarized

How Are Artificial Organs And Bionics Redefining Human Longevity And Functionality?

Artificial organs and bionics are revolutionizing the landscape of modern medicine by offering life-saving and life-enhancing alternatives for patients with failing organs or lost bodily functions. From artificial hearts and kidneys to cochlear implants and bionic limbs, this sector merges biomedical engineering with robotics, electronics, and advanced materials. Artificial organs serve as vital bridges to transplants or long-term solutions where donor shortages persist. Bionics, meanwhile, restore movement, hearing, or vision-enabling patients to regain independence and quality of life. These innovations are especially critical for aging populations, where chronic diseases are prevalent. The integration of neural interfaces, haptic feedback, and real-time monitoring has made modern bionics more responsive and lifelike than ever before. Exoskeletons for rehabilitation and mobility in paraplegic patients, as well as 3D-printed organ scaffolds, are pushing boundaries previously thought impossible. Continuous improvement in miniaturization, battery life, and implantable biosensors is creating smarter, more patient-adaptive devices. This convergence of disciplines is moving healthcare toward a future where disability is no longer a permanent limitation, and organ failure no longer a death sentence.

What Technological Breakthroughs Are Accelerating Innovation In This Field?

Innovation in artificial organs and bionics is being propelled by breakthroughs in regenerative medicine, biomaterials, AI-enabled diagnostics, and robotics. Bio-printing technologies are enabling the creation of vascularized organ structures that can mimic natural tissue properties. Advances in tissue engineering now allow lab-grown skin, corneas, and even cartilage to be integrated with synthetic implants. Neural-linked prosthetics, driven by brain-machine interfaces (BMIs), enable intuitive control through thought, opening new possibilities for amputees and spinal cord injury patients. Sensors embedded in prosthetic limbs provide real-time feedback, such as grip strength or surface texture, which significantly improves user experience. In artificial hearts and ventricular assist devices (VADs), magnetically levitated rotors and energy-efficient motors have enhanced safety and extended device longevity. Wearable bionics, including powered exosuits, are becoming lighter and more affordable thanks to carbon fiber composites and AI-based motion pattern recognition. Nanocoatings and antimicrobial surfaces are improving the biocompatibility of implants, reducing infection risks. As machine learning algorithms become more sophisticated, they are enabling dynamic adjustments in insulin pumps, pacemakers, and renal assist devices, offering personalized performance with predictive healthcare insights.

Are Societal, Ethical, And Economic Factors Influencing Market Trajectory?

As the artificial organ and bionics market matures, its trajectory is increasingly shaped by social acceptance, ethical debates, and reimbursement policies. Public perception is evolving as success stories of bionic limbs or artificial pancreas systems enter mainstream media, but ethical questions about human enhancement, identity, and access remain. The line between restoration and augmentation is blurring, leading to debates on what constitutes “normal” health. Cost remains a critical barrier, especially in developing regions, where access to advanced prosthetics and implantable devices is still limited. Health insurance systems in many countries are under pressure to cover more of these expensive technologies, yet budget constraints remain. There’s also a shortage of trained professionals to handle complex bionic systems, particularly in post-implantation rehabilitation. Global health disparities are influencing where and how these technologies are adopted. Meanwhile, patient advocacy groups are demanding faster regulatory approvals for life-saving devices. Efforts by governments and NGOs to fund research and offer subsidies are gaining momentum, but widespread accessibility remains a challenge. Balancing innovation, ethics, and affordability will be key to unlocking the full potential of this transformative sector.

The Growth In The Artificial Organs And Bionics Market Is Driven By Several Factors…

…including the rising prevalence of chronic and degenerative diseases, the global shortage of organ donors, and increasing investments in medical innovation. The aging global population, particularly in Europe and Japan, is contributing to a surge in demand for renal replacement therapies, cardiovascular implants, and hearing aids. Technological readiness has made these devices more accurate, compact, and reliable, encouraging adoption among healthcare providers. In emerging economies, rising healthcare infrastructure and growing insurance coverage are facilitating market penetration. The rehabilitation sector is expanding with demand for wearable bionic exoskeletons in both medical and military settings. Consumer behavior is shifting, too-patients are increasingly informed and open to adopting body-integrated technologies that enhance lifestyle and autonomy. In high-income markets, elective use of bionic solutions for athletic performance or functional enhancement is also emerging. Research collaborations between medical institutions and tech firms are leading to faster prototyping, testing, and commercialization. The availability of cloud-based health data integration in newer models allows remote monitoring and predictive care, which is particularly attractive to telemedicine platforms. These trends, underpinned by regulatory support and a strong innovation pipeline, are solidifying the market’s upward trajectory.

SCOPE OF STUDY:

The report analyzes the Artificial Organs and Bionics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Artificial Organs, Artificial Bionics); Technology (Mechanical Bionics Technology, Electronic Bionics Technology)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Berlin Heart GmbH
  • Bornlife Prosthetic and Orthotic Inc.
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Edwards Lifesciences Corporation
  • Ekso Bionics Holdings Inc.
  • Getinge AB (Getinge Group)
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • Ossur
  • Sonova
  • SynCardia Systems, LLC
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Artificial Organs and Bionics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Organ Failure Cases Drive Demand for Artificial Organs
    • Technological Innovations in Bionic Limbs Improve Mobility and Quality of Life
    • Increased Investment in 3D Bioprinting of Tissues Accelerates Market Expansion
    • Growing Use of Neural Interfaces in Bionics Enhances Functional Capabilities
    • Shortage of Organ Donors Boosts Development of Artificial Alternatives
    • Surging Demand for Wearable and Implantable Health Devices Fuels Bionic Integration
    • Advancements in Smart Prosthetics Offer Customization and Real-Time Feedback
    • Expanding Application in Military and Rehabilitation Drives Innovation
    • Insurance Coverage for Artificial Organs Encourages Patient Adoption
    • Emergence of Soft Robotics in Artificial Organ Development Improves Biocompatibility
    • AI-Driven Control Systems in Bionics Enhance Patient Outcomes
    • Growing Geriatric Population with Chronic Organ Diseases Supports Long-Term Growth
    • Cross-Sector Collaborations in Biotech and Engineering Foster Breakthroughs
    • Global Expansion of Transplant Centers and Medical Facilities Drives Market Reach
    • Increased Funding from Government and Private Institutions Spurs R&D Progress
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Organs and Bionics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Organs and Bionics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Artificial Bionics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Artificial Bionics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Mechanical Bionics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Mechanical Bionics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Electronic Bionics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Electronic Bionics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 13: USA 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 14: USA Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 17: Canada 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: Canada 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • JAPAN
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Japan 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • CHINA
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 24: China Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: China 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 26: China Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • EUROPE
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 28: Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: Europe 6-Year Perspective for Artificial Organs and Bionics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Europe 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • FRANCE
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 34: France Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: France 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 36: France Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: France 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • GERMANY
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Germany 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • ITALY
    • TABLE 42: Italy Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Italy 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 46: UK Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: UK 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 48: UK Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: UK 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 54: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Asia-Pacific 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 58: Rest of World Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of World 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Rest of World 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030

IV. COMPETITION